Skip to main content
OpenTrials

Clinical trial condition

Post-polycythemia Vera Myelofibrosis

Explore clinical trials studying Post-polycythemia Vera Myelofibrosis. Study availability and eligibility vary by location and protocol.

24 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Post-polycythemia Vera Myelofibrosis trial results

Active, Not Recruiting

Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)

NCT04603495

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 156 locations
View Trial Details
Active, Not Recruiting

An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions

NCT04717414

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +5 more
Locations
  • Local Institution - 110 Los Angeles, California, United States
  • Local Institution - 135 Orlando, Florida, United States
  • Local Institution - 133 Plantation, Florida, United States
  • Local Institution - 112 Chicago, Illinois, United States
View all 185 locations
View Trial Details
Active, Not Recruiting

INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders

NCT04455841

Conditions
Anemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope Orange County Irvine, California, United States
  • Usc Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Stanford Cancer Center Palo Alto, California, United States
View all 34 locations
View Trial Details
Active, Not Recruiting

A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis

NCT03165734

Conditions
Anemia, Blood Platelet Disorders, Bone Marrow Diseases, +11 more
Locations
  • University of Alabama at Birmingham, (UAB) Hospital, Comprehensive Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 207 locations
View Trial Details

Related conditions